Dainippon Pharma, Healios Startup Form iPS Research, Development JV
This article was originally published in PharmAsia News
Executive Summary
Two Japan companies, Dainippon Sumitomo Pharma and Healios K.K., plan a joint venture for developing age-related macular degeneration treatments based on induced pluripotent stem cells.